Adam S. Faye, MD, discusses his team’s research on how antibiotics increase the risk for inflammatory bowel disease among older adults and what clinicians should keep in mind.
Researchers estimated the global, regional, and national prevalence of hepatitis B virus in addition to mortality and disability-adjusted life-years from 1990 to 2019.
Researchers assessed the effect of triple therapy with ribavirin plus sofosbuvir and daclatasvir on sustained virologic response achievement in patients with hepatitis C complicated by cirrhosis.
Researchers sought to determine if there was a stronger association between the Western-style diet and colorectal cancer among individuals with tumors containing higher amounts of pks+ Escherichia coli.
Adults at risk of hepatitis A and hepatitis B have multi-dose vaccinations available, but complete and timely vaccination adherence rates are low. What can be done to encourage more vaccine adherence?
Researchers assessed whether the COVID-19 pandemic influenced the annual incidence of Clostridioides difficile infections among patients in the Netherlands.
Researchers assessed variations in cortisol concentrations among children and adolescents with acute illnesses and no history of glucocorticoid deficiency.
Among persons who inject drugs with chronic HCV infection, the proportion in whom HCV RNA was detected decreased from 100 to 48 percent from 2006 to 2019.
Researchers sought to analyze bacterial-derived metabolites, particularly TMAO pathway and SCFA, of patients with PD and compare the metabolites with control individuals within their households and patients with MSA.
Researchers assessed the effectiveness of both sofosbuvir/velpatasvir and gelcaprevir/pibrentasvir among patients infected with hepatitis C genotype 6.
Studies show fecal microbiota transplantation (FMT) can help patients with ulcerative colitis (UC) achieve remission, but challenges must be addressed before FMT can become a standard of treatment for UC.
